Imprivata Achieves 51 Percent Single Sign-on Market Share Amongst U.S. Hospitals Using McKesson Paragon or Horizon EMR Systems, According to HIMSS Analytics

Published on:

Lexington, MA, July 30, 2014 -- Imprivata® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today announced that Imprivata OneSign® is the most widely selected single sign-on (SSO) solution amongst U.S. hospitals using McKesson Paragon or Horizon electronic medical records (EMR) systems with a 51 percent market share (an increase of about 11 percent in the last 12 months), according to HIMSS Analytics data. Imprivata will showcase its SSO, authentication and access management solutions as well as Imprivata Cortext®, the secure communications platform for healthcare, in booth #713 at InSight365: 2014 Annual Conference (August 5-8, 2014 in Indianapolis, Ind.).

In addition, Imprivata customer Philip Bierdz, infrastructure manager at Riverside Medical Center (Bourbonnais, Ill.), will deliver a presentation titled “Single Sign-on: Is it Worth the Investment?” (session #3156) on Thursday, August 7 at 9:15 a.m. in room 139. In this session, Bierdz will discuss how Riverside Medical Center uses Imprivata OneSign to enable fast, secure access to its McKesson EMR system and other clinical applications. Bierdz will also walk attendees through the complete process of implementing an SSO solution, from the initial selection to maximizing the benefits. Attendees will gain an understanding of the costs and benefits of SSO applications and also see a live demonstration of Imprivata OneSign.

About Imprivata
Imprivata is a leading provider of authentication and access management solutions for the healthcare industry. Imprivata’s single sign-on, authentication management and secure communications solutions enable fast, secure and more efficient access to healthcare information technology systems to address multiple security challenges and improve provider productivity for better focus on patient care. For more information, please visit http://www.imprivata.com.

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup